Select Publications

Book Chapters

Marriott D; Post JJ, 2009, 'Approach to gastrointestinal symptoms', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, edn. 2009, Australasian Society for HIV Medicine Inc., Darlinghurst, NSW, pp. 183 - 187

Journal articles

Chaudhri K; Stocker SL; Williams KM; McLeay RC; Marriott DJE; Di Tanna GL; Day RO; Carland JE, 2020, 'Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package', The Journal of antimicrobial chemotherapy, vol. 75, pp. 1981 - 1984, http://dx.doi.org/10.1093/jac/dkaa098

Abdul-Aziz MH; Alffenaar JWC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA, 2020, 'Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#', Intensive Care Medicine, vol. 46, pp. 1127 - 1153, http://dx.doi.org/10.1007/s00134-020-06050-1

Cattaneo D; Corona A; De Rosa FG; Gervasoni C; Kocic D; Marriott DJ, 2020, 'The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology', Expert Review of Clinical Pharmacology, vol. 13, pp. 355 - 366, http://dx.doi.org/10.1080/17512433.2020.1759413

Sandaradura I; Goeman E; Pontivivo G; Fine E; Gray H; Kerr S; Marriott D; Harkness J; Andresen D, 2020, 'A close shave? Performance of P2/N95 respirators in healthcare workers with facial hair: results of the BEARDS (BEnchmarking Adequate Respiratory DefenceS) study', Journal of Hospital Infection, vol. 104, pp. 529 - 533, http://dx.doi.org/10.1016/j.jhin.2020.01.006

Lau C; Marriott D; Gould M; Andresen D; Reuter SE; Penm J, 2020, 'A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients', Journal of Antimicrobial Chemotherapy, vol. 75, pp. 718 - 725, http://dx.doi.org/10.1093/jac/dkz476

Cattaneo D; Baldelli S; Cozzi V; Clementi E; Marriott DJE; Gervasoni C, 2020, 'Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review', Therapeutic drug monitoring, vol. 42, pp. 64 - 74, http://dx.doi.org/10.1097/FTD.0000000000000684

Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M, 2020, 'Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics', Therapeutic drug monitoring, vol. 42, pp. 83 - 92, http://dx.doi.org/10.1097/FTD.0000000000000710

Märtson AG; Sturkenboom MGG; Stojanova J; Cattaneo D; Hope W; Marriott D; Patanwala AE; Peloquin CA; Wicha SG; van der Werf TS; Tängdén T; Roberts JA; Neely MN; Alffenaar JWC, 2020, 'How to design a study to evaluate therapeutic drug monitoring in infectious diseases?', Clinical Microbiology and Infection, http://dx.doi.org/10.1016/j.cmi.2020.03.008

Ong CW; Chen SCA; Clark JE; Halliday CL; Kidd SE; Marriott DJ; Marshall CL; Morris AJ; Morrissey CO; Roy R; Slavin MA; Stewardson AJ; Worth LJ; Heath CH, 2019, 'Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases', Internal Medicine Journal, vol. 49, pp. 1229 - 1243, http://dx.doi.org/10.1111/imj.14612

Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG, 2019, 'Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting', Clinical Microbiology and Infection, vol. 25, pp. 1286.e1 - 1286.e7, http://dx.doi.org/10.1016/j.cmi.2019.02.029

Biswas C; Marcelino VR; Van Hal S; Halliday C; Martinez E; Wang Q; Kidd S; Kennedy K; Marriott D; Morrissey CO; Arthur I; Weeks K; Slavin MA; Sorrell TC; Sintchenko V; Meyer W; Chen SCA, 2019, 'Corrigendum: Whole genome sequencing of australian candida glabrata isolates reveals genetic diversity and novel sequence types (Front. Microbiol., (2018), 9, (2946), 10.3389/fmicb.2018.02946)', Frontiers in Microbiology, vol. 10, http://dx.doi.org/10.3389/fmicb.2019.02218

Gould M; Ginn AN; Marriott D; Norris R; Sandaradura I, 2019, 'Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae', International Journal of Antimicrobial Agents, vol. 54, pp. 240 - 244, http://dx.doi.org/10.1016/j.ijantimicag.2019.05.013

Cao M; Ellis JT; Marriott D; Harkness J; Stark D, 2019, 'Evaluation of the EasyScreen Protozoan Detection Kit for the diagnosis of Entamoeba histolytica', Pathology, vol. 51, pp. 426 - 428, http://dx.doi.org/10.1016/j.pathol.2019.01.012

Keighley C; Chen SCA; Marriott D; Pope A; Chapman B; Kennedy K; Bak N; Underwood N; Wilson HL; McDonald K; Darvall J; Halliday C; Kidd S; Nguyen Q; Hajkowicz K; Sorrell TC; Van Hal S; Slavin MA, 2019, 'Candidaemia and a risk predictive model for overall mortality: A prospective multicentre study', BMC Infectious Diseases, vol. 19, http://dx.doi.org/10.1186/s12879-019-4065-5

Milliken E; De Zwart AES; Alffenaar JWC; Marriott DJE; Riezebos-Brilman A; Schteinman A; Evans AM; Glanville AR; Verschuuren EAM; Reuter SE, 2019, 'Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens', Journal of Antimicrobial Chemotherapy, vol. 74, pp. 691 - 698, http://dx.doi.org/10.1093/jac/dky466

Overton K; Mennon V; Mothobi N; Neild B; Martinez E; Masters J; Grant P; Akhunji Z; Su WY; Torda A; Whyte CM; Lloyd A; Weatherall C; Hofmeyr A; Foo H; Brookes K; Marriott D; Sintchenko V; Clezy K; Konecny P; Post JJ, 2018, 'Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement', Internal Medicine Journal, vol. 48, pp. 1514 - 1520, http://dx.doi.org/10.1111/imj.14093

Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2018, 'An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy', European Journal of Clinical Microbiology and Infectious Diseases, vol. 37, pp. 2171 - 2175, http://dx.doi.org/10.1007/s10096-018-3357-9

Dekkers BGJ; Veringa A; Marriott DJE; Boonstra JM; van der Elst KCM; Doukas FF; McLachlan AJ; Alffenaar JWC, 2018, 'Invasive Candidiasis in the Elderly: Considerations for Drug Therapy', Drugs and Aging, vol. 35, pp. 781 - 789, http://dx.doi.org/10.1007/s40266-018-0576-9

Biswas C; Marcelino VR; Van Hal S; Halliday C; Martinez E; Wang Q; Kidd S; Kennedy K; Marriott D; Morrissey CO; Arthur I; Weeks K; Slavin MA; Sorrell TC; Sintchenko V; Meyer W; Chen SCA, 2018, 'Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types', Frontiers in Microbiology, vol. 9, http://dx.doi.org/10.3389/fmicb.2018.02946

Biswas C; Chen SCA; Halliday C; Martinez E; Rockett RJ; Wang Q; Timms VJ; Dhakal R; Sadsad R; Kennedy KJ; Playford G; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V, 2017, 'Whole genome sequencing of candida glabrata for detection of markers of antifungal drug resistance', Journal of Visualized Experiments, vol. 2017, http://dx.doi.org/10.3791/56714

Imani S; Buscher H; Marriott D; Gentili S; Sandaradura I, 2017, 'Too much of a good thing: A retrospective study of β-lactam concentration-toxicity relationships', Journal of Antimicrobial Chemotherapy, vol. 72, pp. 2891 - 2897, http://dx.doi.org/10.1093/jac/dkx209

Biswas C; Chen SCA; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V, 2017, 'Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study', Clinical Microbiology and Infection, vol. 23, pp. 676.e7 - 676.e10, http://dx.doi.org/10.1016/j.cmi.2017.03.014

Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S; Daveson K; Wilson H; Thomas M; Peachey G; Gottlieb T; Lui E; Jozwiak F; Bell SM; Cheong E; Chen SCA; Marshall C; Ferguson C; Bryant M; Reed C; Darvall J; Maddigan V; Boan P; Menon V, 2017, 'Changing epidemiology of candidaemia in Australia', Journal of Antimicrobial Chemotherapy, vol. 72, pp. 1103 - 1108, http://dx.doi.org/10.1093/jac/dkw422

James DR; Golovsky G; Thornton JM; Goodchild L; Havlicek M; Martin P; Krockenberger MB; Marriott DJE; Ahuja V; Malik R; Mor SM, 2017, 'Clinical management of Brucella suis infection in dogs and implications for public health', Australian Veterinary Journal, vol. 95, pp. 19 - 25, http://dx.doi.org/10.1111/avj.12550

Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S, 2017, 'Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422', Journal of Antimicrobial Chemotherapy, vol. 72, pp. 1270, http://dx.doi.org/10.1093/jac/dkx047

Kelly ML; Pinto AN; Suan D; Marriott D; Cooper DA; Pett SL, 2017, 'Managing two decades of visceral leishmaniasis and HIV co-infection: A case report that illustrates the urgent research needs in the field', Sexual Health, vol. 14, pp. 286 - 288, http://dx.doi.org/10.1071/SH16036

Halliday CL; Chen SCA; Kidd SE; van Hal S; Chapman B; Heath CH; Lee A; Kennedy KJ; Daveson K; Sorrell TC; Morrissey CO; Marriott DJ; Slavin MA, 2016, 'Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations', International Journal of Antimicrobial Agents, vol. 48, pp. 453 - 458, http://dx.doi.org/10.1016/j.ijantimicag.2016.07.005

Jensen TO; Darley DR; Goeman EE; Shaw K; Marriott DJ; Glanville AR, 2016, 'Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection', Transplant Infectious Disease, vol. 18, pp. 782 - 784, http://dx.doi.org/10.1111/tid.12580

Kennedy KJ; Daveson K; Slavin MA; van Hal SJ; Sorrell TC; Lee A; Marriott DJ; Chapman B; Halliday CL; Hajkowicz K; Athan E; Bak N; Cheong E; Heath CH; Morrissey CO; Kidd S; Beresford R; Blyth C; Korman TM; Robinson JO; Meyer W; Chen SCA; Clark J; McCormack J; Looke D; Playford EG; Chen S; Gottlieb T; Ananda-Rajah M; Arthur I; Morris A; Chambers S, 2016, 'Mucormycosis in Australia: contemporary epidemiology and outcomes', Clinical Microbiology and Infection, vol. 22, pp. 775 - 781, http://dx.doi.org/10.1016/j.cmi.2016.01.005

Chan D; Barratt J; Roberts T; Phillips O; Šlapeta J; Ryan U; Marriott D; Harkness J; Ellis J; Stark D, 2016, 'Detection of Dientamoeba fragilis in animal faeces using species specific real time PCR assay', Veterinary Parasitology, vol. 227, pp. 42 - 47, http://dx.doi.org/10.1016/j.vetpar.2016.07.025

Barratt J; Chan D; Sandaradura I; Malik R; Spielman D; Lee R; Marriott D; Harkness J; Ellis J; Stark D, 2016, 'Angiostrongylus cantonensis: A review of its distribution, molecular biology and clinical significance as a human pathogen', Parasitology, vol. 143, pp. 1087 - 1118, http://dx.doi.org/10.1017/S0031182016000652

Lee FJ; Marriott D; Bloch M; Richardson R; Mackenzie N; Carr A, 2016, 'Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 1127 - 1129, http://dx.doi.org/10.1093/jac/dkv436

Husain S; Sole A; Alexander BD; Aslam S; Avery R; Benden C; Billaud EM; Chambers D; Danziger-Isakov L; Fedson S; Gould K; Gregson A; Grossi P; Hadjiliadis D; Hopkins P; Luong ML; Marriott DJE; Monforte V; Muñoz P; Pasqualotto AC; Roman A; Silveira FP; Teuteberg J; Weigt S; Zaas AK; Zuckerman A; Morrissey O, 2016, 'The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary', Journal of Heart and Lung Transplantation, vol. 35, pp. 261 - 282, http://dx.doi.org/10.1016/j.healun.2016.01.007

Lindsay PJ; Bond SE; Norris R; Marriott DJE; Miyakis S, 2016, 'Posaconazole therapeutic drug monitoring in a regional hospital setting', Therapeutic Drug Monitoring, vol. 38, pp. 804 - 807, http://dx.doi.org/10.1097/FTD.0000000000000334

Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SCA; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC, 2016, 'Problematic dichotomization of risk for Intensive Care Unit (ICU)-acquired invasive candidiasis: Results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients', Clinical Infectious Diseases, vol. 63, pp. 1463 - 1469, http://dx.doi.org/10.1093/cid/ciw610

Chan D; Barratt J; Roberts T; Lee R; Shea M; Marriott D; Harkness J; Malik R; Jones M; Aghazadeh M; Ellis J; Stark D, 2015, 'The prevalence of Angiostrongylus cantonensis/mackerrasae complex in molluscs from the Sydney region', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0128128

Slavin M; van Hal S; Sorrell TC; Lee A; Marriott DJ; Daveson K; Kennedy K; Hajkowicz K; Halliday C; Athan E; Bak N; Cheong E; Heath CH; Orla Morrissey C; Kidd S; Beresford R; Blyth C; Korman TM; Owen Robinson J; Meyer W; Chen SCA; Clark J; McCormack J; Looke D; Playford EG; Gottlieb T; McMullan B; Ananda-Rajah M; Macesic N; Thursky K; Arthur I; Morris A; Chambers S, 2015, 'Invasive infections due to filamentous fungi other than Aspergillus: Epidemiology and determinants of mortality', Clinical Microbiology and Infection, vol. 21, pp. 490.e1 - 490.e10, http://dx.doi.org/10.1016/j.cmi.2014.12.021

Lau AF; Kabir M; Chen SCA; Playford EG; Marriott DJ; Jones M; Lipman J; McBryde E; Gottlieb T; Cheung W; Seppelt I; Iredell J; Sorrell TC, 2015, 'Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: Development and evaluation of a simple, standard protocol', Journal of Clinical Microbiology, vol. 53, pp. 1324 - 1330, http://dx.doi.org/10.1128/JCM.03239-14

Roberts T; Barratt J; Sandaradura I; Lee R; Harkness J; Marriott D; Ellis J; Stark D, 2015, 'Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0119212

Mubarak N; Sandaradura I; Isaia L; O'Sullivan M; Zhou F; Marriott D; Iredell JR; Harkness J; Andresen D, 2015, 'Non-susceptibility to ceftaroline in healthcare-associated multiresistant MRSA in Eastern Australia', Journal of Antimicrobial Chemotherapy, vol. 70, pp. 2413 - 2414, http://dx.doi.org/10.1093/jac/dkv124

Burrows FS; Carlos LM; Benzimra M; Marriott DJE; Havryk AP; Plit ML; Malouf MA; Glanville AR, 2015, 'Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency', Journal of Heart and Lung Transplantation, vol. 34, pp. 958 - 962, http://dx.doi.org/10.1016/j.healun.2015.01.009

Watts MR; Chan RCF; Cheong EYL; Brammah S; Clezy KR; Tong C; Marriott D; Webb CE; Chacko B; Tobia V; Outhred AC; Field AS; Prowse MV; Bertouch JV; Stark D; Reddel SW, 2014, 'Anncaliia algerae microsporidial myositis', Emerging Infectious Diseases, vol. 20, pp. 185 - 191, http://dx.doi.org/10.3201/eid2002.131126

Stark D; Roberts T; Ellis JT; Marriott D; Harkness J, 2014, 'Evaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples', Diagnostic Microbiology and Infectious Disease, vol. 78, pp. 149 - 152, http://dx.doi.org/10.1016/j.diagmicrobio.2013.10.013

Stark D; Barratt JLN; Roberts T; Marriott D; Harkness JT; Ellis J, 2014, 'Activity of benzimidazoles against Dientamoeba fragilis (Trichomonadida, Monocercomonadidae) in vitro and correlation of beta-tubulin sequences as an indicator of resistance', Parasite, vol. 21, http://dx.doi.org/10.1051/parasite/2014043

Chau MM; Kong DCM; van Hal SJ; Urbancic K; Trubiano JA; Cassumbhoy M; Wilkes J; Cooper CM; Roberts JA; Marriott DJE; Worth LJ, 2014, 'Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014', Internal Medicine Journal, vol. 44, pp. 1364 - 1388, http://dx.doi.org/10.1111/imj.12600

Stark D; Garcia LS; Barratt JLN; Phillips O; Roberts T; Marriott D; Harkness J; Ellis JT, 2014, 'Description of Dientamoeba fragilis cyst and precystic forms from human samples', Journal of Clinical Microbiology, vol. 52, pp. 2680 - 2683, http://dx.doi.org/10.1128/JCM.00813-14

Van Hal SJ; Chen SCA; Sorrell TC; Ellis DH; Slavin M; Marriott DM, 2014, 'Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: A prospective observational cohort study', Journal of Antimicrobial Chemotherapy, vol. 69, pp. 2210 - 2214, http://dx.doi.org/10.1093/jac/dku124

Roberts T; Ellis J; Harkness J; Marriott D; Stark D, 2014, 'Treatment failure in patients with chronic Blastocystis infection', Journal of Medical Microbiology, vol. 63, pp. 252 - 257, http://dx.doi.org/10.1099/jmm.0.065508-0

Kelly S; Marriott D, 2014, 'Miliary pulmonary cryptococcosis', Medical Mycology Case Reports, vol. 6, pp. 22 - 24, http://dx.doi.org/10.1016/j.mmcr.2014.08.004


Back to profile page